Data as of Oct 23
| +0.09 / +3.07%|
The 5 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 27.00 and a low estimate of 1.00. The median estimate represents a +198.01% increase from the last price of 3.02.
The current consensus among 6 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.